{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:08:42Z","timestamp":1788732522459,"version":"build-2803163510"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hypertens Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41440-026-02734-1","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:26:32Z","timestamp":1783668392000},"page":"2620-2629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of electrocardiographic left ventricular hypertrophy with cardiovascular events in hypertensive patients with and without chronic kidney disease"],"prefix":"10.1038","volume":"49","author":[{"given":"Kei","family":"Takahashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Kabutoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Hoshide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuomi","family":"Kario","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"2734_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","volume":"28","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;28:1\u201339.e14.","journal-title":"J Am Soc Echocardiogr"},{"key":"2734_CR2","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1038\/s41440-019-0284-9","volume":"42","author":"S Umemura","year":"2019","unstructured":"Umemura S, Arima H, Arima S, Asayama K, Dohi Y, Hirooka Y, et al. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019). Hypertens Res. 2019;42:1235\u2013481.","journal-title":"Hypertens Res"},{"key":"2734_CR3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.7326\/0003-4819-71-1-89","volume":"71","author":"WB Kannel","year":"1969","unstructured":"Kannel WB, Gordon T, Offutt D. Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study. Ann Intern Med. 1969;71:89\u2013105.","journal-title":"Ann Intern Med"},{"key":"2734_CR4","doi-asserted-by":"publisher","first-page":"549","DOI":"10.2147\/CIA.S180723","volume":"14","author":"W Zhang","year":"2019","unstructured":"Zhang W, Zhou Y, Bai B, Yu S, Xiong J, Chi C, et al. Consistency of left ventricular hypertrophy diagnosed by electrocardiography and echocardiography: the Northern Shanghai Study. Clin Inter Aging. 2019;14:549\u201356.","journal-title":"Clin Inter Aging"},{"key":"2734_CR5","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1093\/ajh\/hpaa083","volume":"33","author":"D Wang","year":"2020","unstructured":"Wang D, Xu JZ, Zhang W, Chen Y, Li J, An Y, et al. Performance of electrocardiographic criteria for echocardiographically diagnosed left ventricular hypertrophy in Chinese Hypertensive Patients. Am J Hypertens. 2020;33:831\u20136.","journal-title":"Am J Hypertens"},{"key":"2734_CR6","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/jhh.2008.102","volume":"23","author":"RL Antikainen","year":"2009","unstructured":"Antikainen RL, Grodzicki T, Beevers DG, Webster J, Jokelainen JJ, Bulpitt CJ. Left ventricular hypertrophy by the Sokolow-Lyon voltage criterion predicts mortality in overweight hypertensive subjects. J Hum Hypertens. 2009;23:20\u20136.","journal-title":"J Hum Hypertens"},{"key":"2734_CR7","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1161\/01.CIR.103.19.2346","volume":"103","author":"J Sundstr\u00f6m","year":"2001","unstructured":"Sundstr\u00f6m J, Lind L, Arnl\u00f6v J, Zethelius B, Andr\u00e9n B, Lithell HO. Echocardiographic and electrocardiographic diagnoses of left ventricular hypertrophy predict mortality independently of each other in a population of elderly men. Circulation. 2001;103:2346\u201351.","journal-title":"Circulation"},{"key":"2734_CR8","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/jch.14692","volume":"25","author":"P Yang","year":"2023","unstructured":"Yang P, Ge Z, Gao J, Liu X, Xu M, Ke H. Evaluation of the electrocardiogram RV(5) \/V(6) criteria in the diagnosis of left ventricular hypertrophy in marathon runners. J Clin Hypertens. 2023;25:638\u201346.","journal-title":"J Clin Hypertens"},{"key":"2734_CR9","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1016\/j.ahj.2010.02.012","volume":"159","author":"GF Salles","year":"2010","unstructured":"Salles GF, Cardoso CR, Fiszman R, Muxfeldt ES. Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension. Am Heart J. 2010;159:833\u201340.","journal-title":"Am Heart J"},{"key":"2734_CR10","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","volume":"395","author":"B Bikbov","year":"2020","unstructured":"Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395:709\u201333.","journal-title":"Lancet"},{"key":"2734_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s10157-021-02049-0","volume":"25","author":"K Nagai","year":"2021","unstructured":"Nagai K, Asahi K, Iseki K, Yamagata K. Estimating the prevalence of definitive chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2021;25:885\u201392.","journal-title":"Clin Exp Nephrol"},{"key":"2734_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2023.100604","volume":"5","author":"NK Rai","year":"2023","unstructured":"Rai NK, Wang Z, Drawz PE, Connett J, Murphy DP. CKD progression risk and subsequent cause of death: a population-based cohort study. Kidney Med. 2023;5:100604.","journal-title":"Kidney Med"},{"key":"2734_CR13","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1681\/ASN.2014070714","volume":"26","author":"S Thompson","year":"2015","unstructured":"Thompson S, James M, Wiebe N, Hemmelgarn B, Manns B, Klarenbach S, et al. Cause of death in patients with reduced kidney function. J Am Soc Nephrol. 2015;26:2504\u201311.","journal-title":"J Am Soc Nephrol"},{"key":"2734_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1161\/HYPERTENSIONAHA.116.07201","volume":"68","author":"S Hoshide","year":"2016","unstructured":"Hoshide S, Yano Y, Haimoto H, Yamagiwa K, Uchiba K, Nagasaka S, et al. Morning and evening home blood pressure and risks of incident stroke and coronary artery disease in the Japanese general practice population. Hypertension. 2016;68:54\u201361.","journal-title":"Hypertension"},{"key":"2734_CR15","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000522508","volume":"147","author":"T Kabutoya","year":"2022","unstructured":"Kabutoya T, Hoshide S, Kario K. Notched P-wave on digital electrocardiogram predicts cardiovascular events in patients with cardiovascular risks: the Japan Morning Surge Home Blood Pressure Study. Cardiology. 2022;147:307\u201314.","journal-title":"Cardiology"},{"key":"2734_CR16","doi-asserted-by":"publisher","first-page":"2343","DOI":"10.1001\/jama.292.19.2343","volume":"292","author":"PM Okin","year":"2004","unstructured":"Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. Jama. 2004;292:2343\u20139.","journal-title":"Jama"},{"key":"2734_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/jch.14136","volume":"23","author":"A Yokota","year":"2021","unstructured":"Yokota A, Kabutoya T, Hoshide S, Kario K. Automatically assessed P-wave predicts cardiac events independently of left atrial enlargement in patients with cardiovascular risks: the Japan Morning Surge-Home Blood Pressure Study. J Clin Hypertens. 2021;23:301\u20138.","journal-title":"J Clin Hypertens"},{"key":"2734_CR18","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sj.jhh.1001166","volume":"15","author":"E Kumpusalo","year":"2001","unstructured":"Kumpusalo E, Lappi J, Miettinen H, Takala J. Prevalence of left ventricular hypertrophy in Finnish primary health care hypertensive patients. J Hum Hypertens. 2001;15:255\u20138.","journal-title":"J Hum Hypertens"},{"key":"2734_CR19","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1097\/HJH.0b013e32833b49cb","volume":"28","author":"QA Truong","year":"2010","unstructured":"Truong QA, Ptaszek LM, Charipar EM, Taylor C, Fontes JD, Kriegel M, et al. Performance of electrocardiographic criteria for left ventricular hypertrophy as compared with cardiac computed tomography: from the rule out myocardial infarction using computer-assisted tomography trial. J Hypertens. 2010;28:1959\u201367.","journal-title":"J Hypertens"},{"key":"2734_CR20","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1177\/1470320309343596","volume":"10","author":"V Barrios","year":"2009","unstructured":"Barrios V, Escobar C, Calder\u00f3n A, Echarri R, Barrios S, Navarro-Cid J. Electrocardiographic left ventricular hypertrophy regression induced by an angiotensin receptor blocker-based regimen in hypertensive patients with diabetes: data from the SARA study. J Renin Angiotensin Aldosterone Syst. 2009;10:168\u201373.","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"2734_CR21","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/S0735-1097(86)80207-8","volume":"8","author":"B Surawicz","year":"1986","unstructured":"Surawicz B. Electrocardiographic diagnosis of chamber enlargement. J Am Coll Cardiol. 1986;8:711\u201324.","journal-title":"J Am Coll Cardiol"},{"key":"2734_CR22","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1161\/01.CIR.60.2.386","volume":"60","author":"EM Antman","year":"1979","unstructured":"Antman EM, Green LH, Grossman W. Physiologic determinants of the electrocardiographic diagnosis of left ventricular hypertrophy. Circulation. 1979;60:386\u201396.","journal-title":"Circulation"},{"key":"2734_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1161\/HYPERTENSIONAHA.108.118026","volume":"53","author":"J Ishikawa","year":"2009","unstructured":"Ishikawa J, Ishikawa S, Kabutoya T, Gotoh T, Kayaba K, Schwartz JE, et al. Cornell product left ventricular hypertrophy in electrocardiogram and the risk of stroke in a general population. Hypertension. 2009;53:28\u201334.","journal-title":"Hypertension"},{"key":"2734_CR24","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/S0895-7061(01)01291-2","volume":"14","author":"PM Okin","year":"2001","unstructured":"Okin PM, Devereux RB, Jern S, Julius S, Kjeldsen SE, Dahl\u00f6f B. Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Am J Hypertens. 2001;14:775\u201382.","journal-title":"Am J Hypertens"},{"key":"2734_CR25","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1253\/circj.71.731","volume":"71","author":"T Shirai","year":"2007","unstructured":"Shirai T, Kasao M, Nozaki M, Nitta S. Evaluation of hypertensive cardiac abnormalities using the Cornell product. Circulation J. 2007;71:731\u20135.","journal-title":"Circulation J"},{"key":"2734_CR26","doi-asserted-by":"publisher","first-page":"e251","DOI":"10.1161\/CIRCULATIONAHA.108.191097","volume":"119","author":"EW Hancock","year":"2009","unstructured":"Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS. AHA\/ACCF\/HRS recommendations for the standardization and interpretation of the electrocardiogram. Circulation. 2009;119:e251\u2013e61.","journal-title":"Circulation"},{"key":"2734_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1291\/hypres.22.1","volume":"22","author":"RB Devereux","year":"1999","unstructured":"Devereux RB, Roman MJ. Left ventricular hypertrophy in hypertension: stimuli, patterns, and consequences. Hypertens Res. 1999;22:1\u20139.","journal-title":"Hypertens Res"},{"key":"2734_CR28","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijcard.2006.10.010","volume":"120","author":"M Aktoz","year":"2007","unstructured":"Aktoz M, Erdogan O, Altun A. Electrocardiographic prediction of left ventricular geometric patterns in patients with essential hypertension. Int J Cardiol. 2007;120:344\u201350.","journal-title":"Int J Cardiol"},{"key":"2734_CR29","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1161\/hc3901.096700","volume":"104","author":"J Mathew","year":"2001","unstructured":"Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, et al. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation. 2001;104:1615\u201321.","journal-title":"Circulation"},{"key":"2734_CR30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1161\/01.CIR.0000083724.28630.C3","volume":"108","author":"PM Okin","year":"2003","unstructured":"Okin PM, Devereux RB, Jern S, Kjeldsen SE, Julius S, Nieminen MS, et al. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study. Circulation. 2003;108:684\u201390.","journal-title":"Circulation"},{"key":"2734_CR31","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1161\/CIRCULATIONAHA.109.865774","volume":"120","author":"P Verdecchia","year":"2009","unstructured":"Verdecchia P, Sleight P, Mancia G, Fagard R, Trimarco B, Schmieder RE, et al. Effects of telmisartan, ramipril, and their combination on left ventricular hypertrophy in individuals at high vascular risk in the ongoing telmisartan alone and in combination with ramipril global end point trial and the telmisartan randomized assessment. Circulation. 2009;120:1380\u20139.","journal-title":"Circulation"},{"key":"2734_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jelectrocard.2020.04.018","volume":"61","author":"S Yi","year":"2020","unstructured":"Yi S, Wang F, Wan M, Yi X, Zhang Y, Sun S. Prediction of stroke with electrocardiographic left ventricular hypertrophy in hypertensive patients: a meta-analysis. J Electrocardiol. 2020;61:27\u201331.","journal-title":"J Electrocardiol"},{"key":"2734_CR33","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/nrneph.2010.157","volume":"7","author":"V Kon","year":"2011","unstructured":"Kon V, Linton MF, Fazio S. Atherosclerosis in chronic kidney disease: the role of macrophages. Nat Rev Nephrol. 2011;7:45\u201354.","journal-title":"Nat Rev Nephrol"},{"key":"2734_CR34","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/s41440-022-01076-y","volume":"46","author":"W Zheng","year":"2023","unstructured":"Zheng W, Mu J, Yan Y, Chu C, Su X, Ren Y, et al. Association of rate- pressure product trajectories at an early age with left ventricular hypertrophy in midlife: a prospective cohort study. Hypertens Res. 2023;46:321\u20139.","journal-title":"Hypertens Res"},{"key":"2734_CR35","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41440-024-01938-7","volume":"48","author":"C Liang","year":"2025","unstructured":"Liang C, Yang F, Huang X, Zhang L, Wang Y. Deep learning assists early-detection of hypertension-mediated heart change on ECG signals. Hypertens Res. 2025;48:681\u201392.","journal-title":"Hypertens Res"}],"container-title":["Hypertension Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02734-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02734-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T22:03:41Z","timestamp":1788732221000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41440-026-02734-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2734"],"URL":"https:\/\/doi.org\/10.1038\/s41440-026-02734-1","relation":{},"ISSN":["0916-9636","1348-4214"],"issn-type":[{"value":"0916-9636","type":"print"},{"value":"1348-4214","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TK has received research funding from Japan Lifeline Co., Ltd. and research grants from Abbott and Biotronik. KK has received research grants from A&D, Omron Healthcare, Fukuda Denshi, and CureApp. All other authors have no conflicts of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}}]}}